Clinical Trial Update: Clinical Outcome of a Patented Pharmaceutical Composition (KT-110) to Treat Alcohol Use Disorder While Avoiding Major Side Effects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for KT-110 aimed at treating alcohol use disorder with focus on minimizing major side effects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• KT-110

Snippet

Sponsor: Kinnov Therapeutics | Conditions: Alcohol Use Disorder | Phase 2 | Status: COMPLETED